Abstract
Calorie restriction (CR) has a variety of effects on extending lifespan and delaying the onset of age-related diseases, and it is accepted as the only established experimental antiaging intervention. Several pharmacological agents that can replicate the beneficial effects of CR, called calorie restriction mimetics (CRMs), have been identified. The nutrient-sensing pathways including those involving sirtuins (especially SIRT1) and mammalian target of rapamycin (mTOR) may regulate the physiology of CR, and candidate CRMs that modulate these specific pathways have been identified and investigated using animal models. In this chapter, we focus on candidate CRMs including sirtuin-activating compounds (STACs) and mTOR inhibitors, their slowing of aging, and methods for evaluation of lifespan and metabolic disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McCay CM, Crowell MF, Maynard LA (1989) The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 5:155–171, discussion 172
Colman RJ, Anderson RM et al (2009) Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325:201–204
Fontana L, Meyer TE, Klein S et al (2004) Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A 101:6659–6663
Meyer TE, Kovacs SJ, Ehsani AA et al (2006) Long-term caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol 47:398–402
Masoro EJ (2005) Overview of caloric restriction and ageing. Mech Ageing Dev 126:913–922
Masoro EJ, Iwasaki K, Gleiser CA et al (1989) Dietary modulation of the progression of nephropathy in aging rats: an evaluation of the importance of protein. Am J Clin Nutr 49:1217–1227
Zimmerman JA, Malloy V, Krajcik R et al (2003) Nutritional control of aging. Exp Gerontol 38:47–52
Ingram DK, Zhu M, Mamczarz J et al (2006) Calorie restriction mimetics: an emerging research field. Aging Cell 5:97–108
Ingram DK, Roth GS (2011) Glycolytic inhibition as a strategy for developing calorie restriction mimetics. Exp Gerontol 46:148–154
Imai S, Armstrong CM, Kaeberlein M et al (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795–800
Guarente L (2011) Franklin H. Epstein lecture: sirtuins, aging, and medicine. N Engl J Med 364:2235–2244
Boily G, Seifert EL, Bevilacqua L et al (2008) SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 3:e1759
Michan S, Sinclair D (2007) Sirtuins in mammals: insights into their biological function. Biochem J 404:1–13
Bordone L, Cohen D, Robinson A et al (2007) SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6:759–767
Civitarese AE, Carling S, Heilbronn LK et al (2007) Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 4:e76
Jiang JC, Wawryn J, Shantha Kumara HM et al (2002) Distinct roles of processes modulated by histone deacetylases Rpd3p, Hda1p, and Sir2p in life extension by caloric restriction in yeast. Exp Gerontol 37:1023–1030
Kaeberlein M, Kirkland KT, Fields S et al (2004) Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol 2:E296
Smith DL Jr, McClure JM, Matecic M et al (2007) Calorie restriction extends the chronological lifespan of Saccharomyces cerevisiae independently of the sirtuins. Aging Cell 6:649–662
Burnett C, Valentini S, Cabreiro F et al (2011) Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477:482–485
Canto C, Gerhart-Hines Z, Feige JN et al (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458:1056–1060
Price NL, Gomes AP, Ling AJ et al (2012) SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15:675–690
Baur JA, Ungvari Z, Minor RK et al (2012) Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov 11:443–461
Howitz KT, Bitterman KJ, Cohen HY et al (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191–196
Wood JG, Rogina B, Lavu S et al (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430:686–689
Valenzano DR, Terzibasi E, Genade T et al (2006) Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 16:296–300
Baur JA, Pearson KJ, Price NL et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342
Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109–1122
Timmers S, Konings E, Bilet L et al (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14:612–622
Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12:21–35
Yilmaz OH, Katajisto P, Lamming DW et al (2012) mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature 486:490–495
Stanfel MN, Shamieh LS, Kaeberlein M et al (2009) The TOR pathway comes of age. Biochim Biophys Acta 1790:1067–1074
Kaeberlein M, Powers RW III, Steffen KK et al (2005) Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310:1193–1196
Jia K, Chen D, Riddle DL (2004) The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 131:3897–3906
Kapahi P, Zid BM, Harper T et al (2004) Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 14:885–890
Harrison DE, Strong R, Sharp ZD et al (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392–395
Kapahi P, Chen D, Rogers AN et al (2010) With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab 11:453–465
Lamming DW, Ye L, Katajisto P et al (2012) Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335:1638–1643
Blagosklonny MV (2010) Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle 9:683–688
Kenyon C, Chang J, Gensch E et al (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366:461–\464
Clancy DJ, Gems D, Harshman LG et al (2001) Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292:104–106
Tatar M, Kopelman A, Epstein D et al (2001) A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292:107–110
Bluher M, Kahn BB, Kahn CR (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299:572–574
Kitada M, Kume S, Imaizumi N et al (2011) Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 60:634–643
Minor RK, Baur JA, Gomes AP et al (2011) SRT1720 improves survival and healthspan of obese mice. Sci Rep 1:70
Pearson KJ, Baur JA, Lewis KN et al (2008) Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8:157–168
Wilkinson JE, Burmeister L, Brooks SV et al (2012) Rapamycin slows aging in mice. Aging Cell 11:675–82
Acknowledgements
This work was supported by a Grant from Novo Nordisk Pharma, a Grant-in-Aid for Scientific Research (C) (24591218), and a Grant for Promoted Research from Kanazawa Medical University (S2012-4) to M. Kitada and by Grants for Collaborative Research (C2012-1) and Specially Promoted Research from Kanazawa Medical University (SR2012-06) and the Fourth Annual Research Award Grant of Japanese Society of Anti-Aging Medicine to D. Koya.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Kitada, M., Koya, D. (2013). The Use of Calorie Restriction Mimetics to Study Aging. In: Tollefsbol, T. (eds) Biological Aging. Methods in Molecular Biology, vol 1048. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-556-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-62703-556-9_8
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-555-2
Online ISBN: 978-1-62703-556-9
eBook Packages: Springer Protocols